Risk Management & Compliance Platform | Parakeet Risk logo
Risk Management & Compliance Platform | Parakeet Risk Updated August 04, 2026

21 CFR Part 11 Audit Trails and Electronic Signatures

Introduction

This page distills what regulated manufacturers and pharma teams must implement to satisfy FDA 21 CFR Part 11 for audit trails and electronic signatures, and how Parakeet Risk supports those controls in practice.

Above‑the‑fold essentials (exact Part 11 lexicon many auditors expect to see in your design docs):

  • tamper‑evident logs

  • previous values retained

  • human‑readable copies

  • independent of the record

  • unique user IDs

  • signature manifestation (name, timestamp, meaning)

    Fast start: Need validation evidence? Request Parakeet’s CSV Validation Pack (URS/IQ/OQ/PQ templates, test scripts, traceability matrix) via Contact Us.

§11.10(e) audit trails

The following elements reflect common auditor expectations for 21 CFR 11.10(e) and are supported by Parakeet’s design patterns:

  • Computer‑generated, time‑stamped audit trails that independently record creation, modification, and deletion actions to regulated records.

  • Entries capture who did what and when (user ID, action, date/time; rationale when required by procedure).

  • No obscuring of prior information: previous values are retained so prior state is reconstructable.

  • Tamper‑evident and access‑controlled; users cannot alter or delete audit history.

  • Audit trail remains independent of the editable record and persists through exports/archival.

  • Retained for the full record retention period and readily available for review and copying in human‑readable and electronic form.

Exportable human‑readable copies

Parakeet produces accurate, human‑readable copies of records paired with their audit history for inspectors:

  • One‑click export bundles the record, signature manifestation (name, timestamp with offset, meaning), and complete audit log.

  • Exports include clear headings, chronological events, previous vs. new values, and user IDs.

  • Automated document creation via Google Docs integration ensures copies are consistent, versioned, and immediately shareable. A note on scope: this content summarizes widely accepted interpretations of 21 CFR Part 11 Subpart B (Electronic Records) and Subpart C (Electronic Signatures). It is not legal advice. For regulated pharma use cases, see Parakeet for Pharma.

What Part 11 Requires: Audit Trails

Audit trails are computer‑generated, time‑stamped event histories that document who did what, when, and why to a regulated electronic record. At minimum, your system design and procedures should ensure:

  • Creation/modification/deletion events are recorded with user ID, date/time, action, and rationale where applicable.

  • Audit entries are tamper‑evident: users cannot alter or delete audit history; administrative tools expose but cannot rewrite entries.

  • Previous values retained: the system stores original and changed values so prior state is reconstructable.

  • Audit trail “independent of the record”: the audit history persists even if the primary record is exported, archived, or corrupted, and is protected by separate permissions.

  • Retention and retrieval: audit trails are retained for the record’s full retention period and are readily retrievable for review.

  • Human‑readable copies: the system can produce accurate and complete copies of records and their audit trails in human‑readable format (and electronic form) for inspection.

What Part 11 Requires: Electronic Signatures

Electronic signatures are the legally binding equivalent of handwritten signatures when specific controls are met. Core expectations include:

  • Identity assurance: each signer has unique user IDs (no shared accounts). Initial identity verification is documented.

  • Signature manifestation: each signed record displays the signer’s name, timestamp (with time zone or clear offset), and the meaning (e.g., creation, review, approval).

  • Signature components and controls: application of the e‑signature requires at least two distinct components (e.g., ID + password or token/biometric) for non‑biometric methods; credential reuse is restricted; attempts are logged.

  • Linkage: the signature is cryptographically or logically bound to the specific record content so it cannot be excised, copied, or repudiated without detection.

  • Periodic re‑authentication: for prolonged sessions, the system prompts for re‑entry of credentials before permitting signing events.

Implementation Checklist (Systems + Procedures)

Use this concise checklist to scope your User Requirements Specification (URS) and SOPs:

  • Access control: unique accounts, role‑based permissions, least‑privilege, disabled shared logins.

  • Time synchronization: authoritative time source; logs include date, time, and offset.

  • Audit trail design: immutable store, append‑only writes, previous values retained, reason for change prompts where appropriate.

  • Reporting and export: human‑readable copies that pair records with their audit trails; machine‑readable exports for investigations.

  • Signature ceremonies: explicit meaning pick‑lists; visible manifestation on signed records; challenge/response for re‑auth.

  • Training and policies: users trained on e‑sign responsibilities; SOPs forbidding credential sharing; periodic effectiveness checks.

  • Record retention: retention schedules align audit trail retention with the underlying GMP record.

  • Vendor qualification + validation: supplier assessment, security due diligence, and risk‑based CSV (URS/IQ/OQ/PQ).

How Parakeet Risk Supports Part 11 Controls

Parakeet is an AI‑native GRC platform built for industrial and pharma teams. Relevant capabilities include:

  • Auditability at scale: centralized, tamper‑evident event histories and robust audit trail/documentation features used across industries like Packaging and Manufacturing.

  • Human‑readable copies: automated report generation via Google Docs integration produces accurate, human‑readable record and audit‑trail bundles for inspectors.

  • Unique user IDs and collaboration: two‑way integrations with Slack and Microsoft Teams maintain accountability while synchronizing discussions back to an auditable system of record.

  • Evidence automation: the Rosella AI Agent assembles audit evidence, extracts regulatory requirements, and drafts meaning dictionaries for signature ceremonies.

  • Scheduling and traceability: Google Calendar and QMS‑friendly workflows (see Pharma) keep sign‑offs and reviews timely and traceable.

Part 11 Control Map (Design Pattern → Platform Support)

Control (21 CFR Part 11) Implementation Pattern Parakeet Support
Audit trails: computer‑generated, time‑stamped; previous values retained; tamper‑evident Append‑only log store; restricted admin tools; required reason‑for‑change fields Centralized audit histories and documentation features in Packaging and Features
Human‑readable copies of records and audit trails One‑click generation of human‑readable copies; paired export of record + history Automated document creation via Google Docs integration
Unique user IDs; authority checks Individual accounts, SSO/IdP integration, least‑privilege roles Role‑driven workflows across Manufacturing and team integrations
Signature manifestation (name, timestamp, meaning) Signature panel captures printed name, date/time (with offset), meaning pick‑list Configurable approval workflows; inspector‑ready report outputs via Docs integration
Record‑signature linkage Hashing/immutable IDs; visible signature blocks bound to record content Immutable references within audit history; export bundles preserve linkage

Validation Pack (URS/IQ/OQ/PQ)

Accelerate compliant deployment with a risk‑based CSV approach:

  • URS (User Requirements Specification): define audit‑trail/e‑signature needs (tamper‑evident logs, independent of the record, human‑readable copies, signature manifestation).

  • IQ (Installation Qualification): verify environment, time sync, security baselines, and integrations (e.g., QMS, Slack/Teams, Google Docs).

  • OQ (Operational Qualification): challenge audit‑trail immutability, previous values retained, error handling, and report generation; test e‑signature ceremonies and re‑authentication.

  • PQ (Performance Qualification): run process‑realistic scenarios (change control, batch record review, CAPA approvals) over representative data volumes.

Call to action: request Parakeet’s Validation Pack (URS/IQ/OQ/PQ templates, test scripts, and traceability matrix) via Contact Us.

FAQs

Q: Is a basic database change log enough for Part 11? A: Not typically. Part 11 expects computer‑generated, time‑stamped, tamper‑evident logs with previous values retained, secured from alteration, and available as human‑readable copies with the record.

Q: How long must audit trails be kept? A: For at least the same retention period as the underlying regulated record. Your records management policy should align both.

Q: Can users share accounts to speed up shop‑floor sign‑offs? A: No. Part 11 relies on unique user IDs and individual accountability. Shared credentials undermine identity assurance and are incompatible with e‑signature controls.

Q: Do we need biometrics for e‑signatures? A: No. Part 11 permits either biometrics or at least two distinct components (e.g., ID + password/token). Choose based on risk and usability.

Q: What does “independent of the record” mean for audit trails? A: The audit trail’s integrity and availability do not depend on the editable portion of the record. Even if a record is updated, exported, or corrupted, the audit history persists and remains protected.

Q: How does Parakeet help during inspections? A: Parakeet generates human‑readable copies of records with their audit trails, provides end‑to‑end traceability via integrations, and uses Rosella to compile evidence packs quickly, supporting rapid, consistent responses. Q: Does FDA certify or approve vendors as “Part 11 compliant”? A: No. FDA does not certify software for Part 11. You must conduct risk‑based Computer Software Validation (CSV) to validate intended use in your process.

Pharma TPRM: 21 CFR Part 11 supplier monitoring

Contract labs, CMOs/CDMOs, and other third parties often create or sign GMP records. Your TPRM program should ensure supplier‑impacted records meet Part 11 controls (audit trails, unique user IDs, signature manifestation, human‑readable copies) and that evidence is readily retrievable during inspections.

How Parakeet helps pharma TPRM:

  • Supplier evidence centralization: capture certificates, method transfers, and batch documentation with immutable audit trails and exportable human‑readable copies. See Parakeet for Pharma: https://www.parakeetrisk.com/pharma

  • Signature oversight: require unique user IDs and signature meaning for supplier sign‑offs; exports bundle signature manifestation and full audit history.

  • Continuous assurance: integrate collaboration and scheduling across supplier reviews via Slack/Teams and Google Calendar; automate document packages via Google Docs. Explore integrations: https://www.parakeetrisk.com/integration

  • Rapid evidence prep: Rosella AI assembles third‑party compliance evidence and traces requirements to records to accelerate inspections and audits.

Last updated: November 25, 2025

Related Parakeet Resources

Compliance Note

This document summarizes requirements commonly associated with 21 CFR Part 11. Your quality unit should approve final URS/SOPs and validation evidence based on your product, process risk, and inspector feedback.